HHS-FDA-22-0116 Archives - American Oversight
Skip to main content
American Oversight
Uncovering the facts,
Holding government accountable.
Donate
Subscribe
Investigations
All Investigations
Voting Rights
Threats to Democracy
Trump Accountability
Abuse of Power
Congressional Investigations
Coronavirus Response
Ethics & Conflicts
Influence & Access
Misconduct
Policy & Regulations
Political Appointees
Corporate Complicity
States
Arizona
Florida
Georgia
Pennsylvania
Texas
Wisconsin
See All States
Documents
News
En Español
Search
Search
Search
FOIA Number: HHS-FDA-22-0116
FOIA to FDA for Communications Sent by FDA Drugs Advisory Committee Regarding Aduhelm
February 2, 2022
FOIA request to the U.S. Food and Drug Administration seeking communications sent by Peripheral and Central Nervous System Drugs Advisory Committee members regarding Aduhelm (aducanumab), an Alzheimer's drug produced by Biogen.
Read more
Pagination